CRISPR/Cas9 technology generated a TGC to CGG change resulting in a cysteine to arginine substitution at amino acid 103 (p.C103R) in the deubiquitinating OUT domain. This mutation impairs deubiquitinase function. (J:343044)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count